Australia markets closed

CNBX Pharmaceuticals Inc. (CNBX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0114+0.0004 (+3.64%)
At close: 03:26PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/08/2023
31/08/2022
31/08/2021
31/08/2020
Cash flows from operating activities
Net income
-1,232
-3,710
-4,392
-3,194
-7,467
Depreciation & amortisation
150.806
162.061
198.527
220.926
215.155
Stock-based compensation
-
180.48
728.869
-
-
Change in working capital
189.402
474.129
407.226
-64.053
148.11
Accounts receivable
-65.688
-13.84
123.603
-10.418
132.197
Other working capital
-195.514
-112.521
-1,681
-2,494
-2,851
Other non-cash items
517.22
2,781
709.436
544.661
4,435
Net cash provided by operating activities
-194.318
-112.521
-1,679
-2,493
-2,775
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-1.656
-0.943
-75.748
Purchases of investments
0
-
-
-
0
Sales/maturities of investments
20
24.702
0
645.968
3,362
Net cash used for investing activities
18.804
24.702
25.229
645.025
3,287
Cash flows from financing activities
Common stock issued
0
-
-
-
0
Net cash used provided by (used for) financing activities
0
100
389.858
2,457
0
Net change in cash
-10.606
12.181
-1,264
608.862
511.629
Cash at beginning of period
47.748
117.515
1,386
777.611
265.982
Cash at end of period
-22.751
129.696
117.515
1,386
777.611
Free cash flow
Operating cash flow
-194.318
-112.521
-1,679
-2,493
-2,775
Capital expenditure
-
-
-1.656
-0.943
-75.748
Free cash flow
-195.514
-112.521
-1,681
-2,494
-2,851